Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China

被引：0
作者：
C. Hutchison
M. S. Khan
J. Yoong
X. Lin
R. J. Coker
机构：
[1] London School of Hygiene and Tropical Medicine,Saw Swee Hock School of Public Health
[2] National University of Singapore,Centre for Economic and Social Research
[3] University of Southern California,Faculty of Public Health
[4] Yunnan Center for Disease Control and Prevention,undefined
[5] Mahidol University,undefined
来源：
BMC Public Health | / 17卷
关键词：
Tuberculosis; Multidrug-resistance; China; Barriers; Qualitative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China [J].
Kefyalew Addis Alene ;
Hengzhong Yi ;
Kerri Viney ;
Emma S. McBryde ;
Kunyun Yang ;
Liqiong Bai ;
Darren J. Gray ;
Archie C. A. Clements ;
Zuhui Xu .
BMC Infectious Diseases, 17
[22]   Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China [J].
Alene, Kefyalew Addis ;
Yi, Hengzhong ;
Viney, Kerri ;
McBryde, Emma S. ;
Yang, Kunyun ;
Bai, Liqiong ;
Gray, Darren J. ;
Clements, Archie C. A. ;
Xu, Zuhui .
BMC INFECTIOUS DISEASES, 2017, 17
[23]   Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment [J].
Seddon, James A. ;
Johnson, Sarah ;
Palmer, Megan ;
van Der Zalm, Marieke M. ;
Lopez-Varela, Elisa ;
Hughes, Jennifer ;
Schaaf, H. Simon .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (02) :221-237
[24]   Tuberculosis treatment interruption: a qualitative exploration of barriers, challenges, coping strategies and facilitators in Malaysia [J].
Oh, Ai Ling ;
Makmor-Bakry, Mohd ;
Islahudin, Farida ;
Ting, Chuo Yew ;
Chan, Swee Kim ;
Tie, Siew Teck .
HEALTH PROMOTION INTERNATIONAL, 2024, 39 (06)
[25]   Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China [J].
Tang, Shenjie ;
Yao, Lan ;
Hao, Xiaohui .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[26]   Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi?an China, a Retrospective Cohort Study [J].
Ma, Jin-Bao ;
Zeng, Ling-Cheng ;
Ren, Fei ;
Dang, Li-Yun ;
Luo, Hui ;
Wu, Yan-Qin ;
Yang, Xin-Jun ;
Li, Rong ;
Yang, Han ;
Xu, You .
INFECTION AND DRUG RESISTANCE, 2022, 15 :4947-4957
[27]   Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study [J].
Hu, Yi ;
Zheng, Xubin ;
Forsman, Lina Davies ;
Ning, Zhu ;
Chen, Cheng ;
Gao, Yazhou ;
Zhang, Zhengdong ;
Lu, Wei ;
Werngren, Jim ;
Bruchfeld, Judith ;
Hoffner, Sven ;
Xu, Biao .
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) :1805-1813
[28]   High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China [J].
Chen, Ling ;
Li, Nana ;
Liu, Mei ;
Zhang, Jianyong ;
Zhang, Hong .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) :2435-2437
[29]   Risk factors of multidrug-resistant tuberculosis in China: A meta-analysis [J].
Feng, Mei ;
Xu, YuanGao ;
Zhang, XiangYan ;
Qiu, Qian ;
Lei, ShiGuang ;
Li, JinLan ;
Yuan, Wei ;
Song, QunFeng ;
Xu, JinHong .
PUBLIC HEALTH NURSING, 2019, 36 (03) :257-269
[30]   Risk factors for multidrug-resistant tuberculosis: a predictive model study [J].
Wu, Lianpeng ;
Cai, Xiaoxiao ;
Jiang, Xiangao .
FRONTIERS IN MEDICINE, 2024, 11
12345